Johnson & Johnson (NYSE:JNJ) Releases FY 2023 Earnings Guidance

Johnson & Johnson (NYSE:JNJ – Get Free Report) updated its FY 2023 earnings guidance on Monday. The company provided EPS guidance of 9.900-9.960 for the period, compared to the consensus EPS estimate of 9.160. The company issued revenue guidance of -. Johnson & Johnson also updated its FY 2024 guidance to 10.550-10.750 EPS. Analyst Ratings […]

Leave a Reply

Your email address will not be published.

Previous post Lost in the mix of Medicaid ‘Unwinding’: Kentucky cut off her health care over a clerical error
Next post Point72 Europe London LLP Purchases New Holdings in Mastercard Incorporated (NYSE:MA)